Evidence-Based Complementary and Alternative Medicine / 2013 / Article / Tab 2

Review Article

Acupuncture and Moxibustion for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Table 2

Characteristics and methodological quality of included studies.

StudySample size ( / )Sex (male/female)Age (mean or range)Type of IBDFollowupMethodology quality score

Ma and Zhang, 1997 [3]90 (60/30)56/34 : 23–68; : 28–65UCNo1
Gao, 1997 [4]66 (46/20)27/39 : 43.6; : 39.5UCNo1
Wu et al., 1999 [5]151 (65/56/30)ND : 42.7; : 38.4UCNo1
Li et al., 2008 [6]67 (34/33)42/2535.5UCNo1
Mo et al., 2010 [7]62 (31/31)35/2735.5UCNo1
X. Guo and F. Guo, 2010 [8]55 (28/27)38/1738.77UCNo1
Yang et al., 2011 [9]100 (50/50)61/39 : 54.6; : 55.3UCNo1
Zhou and Jin, 2008 [10]220 (110/110)131/89 : 48.60; : 50.24UCYes4
Han et al., 2012 [11]81 (41/40)47/34 : 36.5; : 34.7UCNo1
Jiang, 2012 [12]80 (40/40)39/41 : 38.65; : 39.35UCNo3
Zhou, 2003 [13]66 (34/32)31/3540.8UCNo1
Din et al., 2009 [14]61 (30/31)32/29 : 44.9; : 40.2UCNo1
Wu et al., 2000 [15]46 (30/16)25/21 : 38.75; : 37UCNo1
Wen, 2003 [16]69 (39/30)35/34 : 41.2; : 37.4UCNo1
Wang et al., 2006 [17]60 (30/30)28/3238.5UCNo1
Xu et al., 2010 [18]60 (28/32)35/25 : 35.0; : 37.0UCNo2
Zhang, 2012 [19]60 (30/30)32/28 : 28–52; : 27–55UCNo1
Chi and Yu, 2011 [20]84 (44/40)36/48 : 45; : 43UCNo1
Luo, 2009 [21]76 (40/36)42/34 : 53; : 51.3UCNo1
Li et al., 2006 [22]68 (40/28)40/28 : 36.4; : 38.2UCYes1
Tian et al., 2012 [23]106 (53/53)46/60 : 29–61; : 32–63UCNo1
Chen, 2004 [24]130 (100/30)80/50 : 42.5; : 40.2UCNo1
Li et al., 2006 [25]116 (56/60)52/64 : 37.1; : 37.3UCNo2
Duan et al., 2012 [26]640 (320/320)406/234 : 45.5; : 46.5UCNo1
Sun and Wang, 1998 [27]88 (45/43)43/45 : 34.6; : 33.8UCNo1
Wang, 2008 [28]108 (54/54)78/30 : 35; : 33.5UCNo1
Ma and Xu, 2005 [29]92 (47/45)51/41 : 52.5; : 52.5UCNo2
Cui, 2010 [30]48 (24/24)27/21 : 43; : 44UCNo2
Guo et al., 2007 [31]33 (22/11)NDNDUCNo1
Wang et al., 2009 [32]78 (39/39)44/34 : 57.5; : 55.0UCNo1
Long and Yang, 2010 [33]46 (23/23)20/26 : 33.5; : 33.4UCNo1
Chen, 2010 [34]168 (84/84)91/7738.4UCNo1
Sun and Wang, 2001 [35]55 (35/20)32/23 : 22–65; : 25–70UCNo1
Wang et al., 2006 [36]45 (27/18)23/2240.5UCNo1
Shi et al., 2006 [37]60 (30/30)34/26 : 42.31; : 43.64UCNo2
Qun et al., 2012 [38]63 (33/30)32/31 : 46; : 41UCNo1
Xu, 2006 [39]110 (56/54)59/51 : 35.5; : 33UCNo1
Zhang et al., 2011 [40]60 (30/30)38/22 : 31.2; : 30.6UCNo2
Joos et al., 2006 [41]29 (15/14)10/19 UCYes7
Yang and Yan, 1999 [42]62 (32/30)30/32 : 45.5; : 50.1UCNo1
Joos et al., 2004 [43]51 (27/24)15/36NDCDYes5
Ma, 1999 [44]90 (60/30)56/34 : 23–68; : 28–65UCNo1
Ma, 2005 [45]121 (76/45)67/54 : 42; : 41.5UCNo1

: sample size of test group; : sample size of control group; : test group; : control group; ND: not described; IBD: inflammatory bowel disease; UC: ulcerative colitis; CD: Crohn’s disease.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.